Publicaciones en las que colabora con Rosario García de Vicuña (9)

2019

  1. Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 63-68

2017

  1. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202

  2. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases

    Reumatologia Clinica, Vol. 13, Núm. 4, pp. 210-213

2011

  1. Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis

    PLoS ONE, Vol. 6, Núm. 12

2010

  1. Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker

    European Cytokine Network, Vol. 21, Núm. 3, pp. 186-194

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2004

  1. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients

    Arthritis and Rheumatism, Vol. 50, Núm. 12, pp. 3866-3877

1992

  1. MEMBRANA SINOVIAL EN LA ARTRITIS REUMATOIDE: INFILTRADO DE CELULAS MONONUCLEARES

    Revista Espanola de Reumatologia, Vol. 19, Núm. 9, pp. 399-411

1989

  1. Systemic lupus erythematosus and tetrasomy-X

    Journal of Rheumatology, Vol. 16, Núm. 11, pp. 1486-1488